About

Lars Berger is an accomplished professional with over 30 years of international experience driving innovation and growth in the medical device and healthcare industries. As Senior Manager of Portfolio Strategy and Customer Solutions at SHL Medical, he focuses on building and optimising the product portfolio by identifying opportunities based on customer needs, technical limitations and regulatory requirements.

He has previously led over 15 development projects for pharma companies including Johnson & Johnson and Sanofi, including pioneering advancements in diagnostics, drug delivery devices, disease management applications and software as medical devices. He holds a master’s degree in Business Science from the University of Regensburg (Germany).

Contributions

INJECTION

SHL MOLLY^® AUTOINJECTORS: POWERING THE NEXT WAVE OF CARDIOMETABOLIC CARE

Lars Berger and Eric Linvill discuss the rapid growth of the cardiometabolic disease space in light of the global obesity epidemic and how advanced autoinjector and injection pen technologies, such as SHL Medical’s Molly platform, will be necessary to meet the challenges presented by this disease area.